InflaRx (IFRX) EBIT (2016 - 2026)

InflaRx has disclosed EBIT across 11 years of filings, most recently posting -$8.4 million for Q1 2026.

• EBIT for Q1 2026 came in at -$8.4 million, up 38.31% year-over-year; the trailing twelve-month figure through Mar 2026 was $7.1 million (up 870.36% YoY), and the FY2025 annual result was -$56.18, up 0.83% from the prior year.
• EBIT came in at -$8.4 million for Q1 2026 at InflaRx, down from $41.2 million in the prior quarter.
• In the past five years, EBIT ranged from a high of $46.2 million in Q4 2024 to a low of -$16.9 million in Q3 2024.
• The 5-year median for EBIT is -$11.1 million (2025), against an average of -$4.1 million.
• Across the five-year window, EBIT sank 140083597.94% in 2023 and jumped 422.78% in 2024, its largest moves.
• InflaRx's EBIT stood at -$7.9 million in 2022, then tumbled by 82.27% to -$14.3 million in 2023, then soared by 422.78% to $46.2 million in 2024, then slipped by 10.83% to $41.2 million in 2025, then plunged by 120.48% to -$8.4 million in 2026.
• The last three EBIT figures came in at -$8.4 million (Q1 2026), $41.2 million (Q4 2025), and -$11.1 million (Q3 2025), per Business Quant data.